This site is intended for healthcare professionals
Abstract digital waveforms in blue and purple
  • Home
  • /
  • Drugs
  • /
  • A
  • /
  • ACD-A
  • /
  • ACD-A ANHYDROUS CITRIC ACID 730 mg/100mL Fenwal, Inc.
FDA Drug information

ACD-A

Read time: 1 mins
Marketing start date: 12 Jan 2025

Summary of product characteristics


Warnings

WARNINGS Do Not Use Unless Solution is Clear and Seal is Intact

Effective Time

20221101

Version

9

Spl Product Data Elements

ACD-A Antiocoagulant Citrate Dextrose Solution, Formula A DEXTROSE MONOHYDRATE ANHYDROUS DEXTROSE SODIUM CITRATE, UNSPECIFIED FORM ANHYDROUS CITRIC ACID ANHYDROUS CITRIC ACID ANHYDROUS CITRIC ACID

Application Number

BN160918

Brand Name

ACD-A

Generic Name

Antiocoagulant Citrate Dextrose Solution, Formula A

Product Ndc

0942-9005

Product Type

HUMAN PRESCRIPTION DRUG

Route

INTRAVENOUS

Package Label Principal Display Panel

PACKAGE/LABEL PRINCIPAL DISPLAY PANEL Hotstamp

How Supplied

HOW SUPPLIED Sterile, Non-pyrogenic

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.

Disclaimer

The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).

Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.

Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.